Diet showdown: three meal plans battle scleroderma belly bloat
NCT ID NCT07402226
First seen Feb 28, 2026 · Last updated Jun 22, 2026 · Updated 13 times
Summary
This study compares three different diets to see which best reduces bloating and other gut symptoms in people with systemic sclerosis (scleroderma). Sixty participants will follow a low FODMAP diet, a gut-healing elimination diet, or a standard healthy-eating diet for six weeks, all with help from a dietitian. The goal is to find a practical, non-drug way to improve quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS (SSC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dietary intervention (low FODMAP, CDED, or NICE diet)
What this could lead to
If successful, this could provide a simple, drug-free way to manage bloating and abdominal pain in people with systemic sclerosis.
What could go wrong
This is a small, early-stage trial with only 60 participants. Diets may be hard to follow long-term, and results may not apply to everyone with scleroderma.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.